[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342056-105":59,"doc-detail-342056-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","an-rna-damage-response-network-mediates-the-lethality-of-5-fu-in-colorectal-cancer","An RNA damage response network mediates the lethality of 5-FU in colorectal cancer","","5-fluorouracil (5-FU), a major anti-cancer therapeutic, has been widely attributed to thymidylate synthase inhibition, depletion of dTTP, and DNA damage. Chen and colleagues show that clinical combinations of 5-FU with oxaliplatin or irinotecan do not produce synergy in colorectal cancer trials and yield sub-additive killing in cell lines. The study links 5-FU efficacy to RNA damage during ribosome biogenesis, driving lysosomal degradation of damaged rRNAs and proteasomal loss of ubiquitylated ribosomal proteins. Upregulating rRNA biogenesis enhances responses, supporting combinatorial targeting.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/an-rna-damage-response-network-mediates-the-lethality-of-5-fu-in-colorectal-cancer/342056/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/an-rna-damage-response-network-mediates-the-lethality-of-5-fu-in-colorectal-cancer/342056.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What mechanism has traditionally been proposed for 5-FU efficacy in cancer?","Question",{"text":112,"@type":113},"5-FU is primarily believed to inhibit thymidylate synthase, deplete dTTP, and induce DNA damage in cancer cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does this study explain 5-FU lethality in colorectal cancer?",{"text":117,"@type":113},"The authors demonstrate that 5-FU-mediated cell killing mainly involves an RNA damage response during ribosome biogenesis, leading to degradation of damaged rRNAs and ubiquitinated ribosomal proteins.",{"name":119,"@type":110,"acceptedAnswer":120},"Do 5-FU combinations with DNA-damaging drugs show synergy in colorectal cancer?",{"text":121,"@type":113},"No. Clinical combinations with oxaliplatin or irinotecan show no synergy in human colorectal cancer trials, and sub-additive killing is observed in colorectal cancer cell lines.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342056,1790113942,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Article  \nAn RNA damage response network mediates the lethality of 5-FU in colorectal cancer  \nGraphical abstract  \nHighlights  \nAuthors  \nJung-Kuei Chen, Karl A. Merrick, Yi Wen Kong, ...,  \nMatthew G. Vander Heiden,¨Omer H. Yilmaz, Michael B. Yaffe  \nCorrespondence  \n[myaffe@mit.edu](myaffe@mit.edu)  \nIn brief  \n5-ﬂuorouracil’s utility in cancer treatment has been attributed to inducing dNTP imbalance and DNA damage in cancer cells. Here, Chen et al. demonstrate that 5-FU’s efﬁcacy results instead from RNA damage during ribosome biogenesis and provide approaches to improve tumor responses to 5-FU by enhancing rRNA production in cancer.  \nd 5-FU does not synergize with DNA-damaging agents such asoxaliplatin or irinotecan  \nd 5-FU incorporation into structured RNAs (primarily rRNA) causes cancer cell death  \nd 5-FU drives lysosomal degradation of rRNA and ubiquitylation of ribosomal proteins  \nd Upregulating rRNA transcription enhances tumor killing following 5-FU treatment  \nChen et al., 2024, Cell Reports Medicine 5, 101778  \nOctober 15, 2024 ª 2024 The Author(s) . Published by Elsevier Inc.  \n[https://doi.org/10.1016/j.xcrm.2024.101778](https://doi.org/10.1016/j.xcrm.2024.101778)  \nll  \nll  \nOPEN ACCESS  \nArticle  \nAn RNA damage response network mediates the lethality of 5-FU in colorectal cancer  \nJung-Kuei Chen,1,10 Karl A. Merrick,1,10 Yi Wen Kong,1 Anita Izrael-Tomasevic,6 George Eng,1 Erika D. Handly,1,3 Jesse C. Patterson,1 Ian G. Cannell,1 Lucia Suarez-Lopez,1 Aaron M. Hosios,1,2 Anh Dinh,1 Donald S. Kirkpatrick,6 Kebing Yu,6 Christopher M. Rose,6 Jonathan M. Hernandez,7 Haeun Hwangbo,8,9 Adam C. Palmer,9  \nMatthew G. Vander Heiden,1,2,4 ¨Omer H. Yilmaz,1,2 and Michael B. Yaffe1,2,3,5,11,*  \n1Center for Precision Cancer Medicine, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA  \n2Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA  \n3Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA  \n4Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA  \n5Department of Surgery, Beth Israel Medical Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA  \n6Genentech Biotechnology company, South San Francisco, CA 94080, USA  \n7Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA  \n8Curriculum in Bioinformatics and Computational Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA  \n9Department of Pharmacology, Computational Medicine Program, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA  \n10These authors contributed equally  \n11Lead contact  \n*[Correspondence:](Correspondence: myaffe@mit.edu)[ myaffe@mit.edu](Correspondence: myaffe@mit.edu)[ ](Correspondence: myaffe@mit.edu)[https://doi.org/10.1016/j.xcrm.2024.101778](https://doi.org/10.1016/j.xcrm.2024.101778)  \nSUMMARY  \n5-ﬂuorouracil (5-FU), a major anti-cancer therapeutic, is believed to function primarily by inhibiting thymidylate synthase, depleting deoxythymidine triphosphate (dTTP), and causing DNA damage. Here, we show that clinical combinations of 5-FU with oxaliplatin or irinotecan show no synergy in human colorectal cancer (CRC) trials and sub-additive killing in CRC cell lines. Using selective 5-FU metabolites, phospho-and ubiquitin proteomics, and primary human CRC organoids, we demonstrate that 5-FU-mediated CRC cell killing primarily involves an RNA damage response during ribosome biogenesis, causing lysosomal degradation of damagedrRNAs and proteasomal degradation of ubiquitinated ribosomal proteins. Tumor types clinically responsive to 5-FU treatment show upregulated rRNA biogenesis while 5-FU clinically non-responsive tumor types do not, instead showing greater sensitivity to 5-FU’s DNA damage effects. Finally, we show tha","cbCaitT9ku4dU7Lj","https://ap.wps.com/l/cbCaitT9ku4dU7Lj","pdf",7237811,27,"English","# Highlights\n# Summary\n# Introduction","[{\"question\":\"What mechanism has traditionally been proposed for 5-FU efficacy in cancer?\",\"answer\":\"5-FU is primarily believed to inhibit thymidylate synthase, deplete dTTP, and induce DNA damage in cancer cells.\"},{\"question\":\"How does this study explain 5-FU lethality in colorectal cancer?\",\"answer\":\"The authors demonstrate that 5-FU-mediated cell killing mainly involves an RNA damage response during ribosome biogenesis, leading to degradation of damaged rRNAs and ubiquitinated ribosomal proteins.\"},{\"question\":\"Do 5-FU combinations with DNA-damaging drugs show synergy in colorectal cancer?\",\"answer\":\"No. Clinical combinations with oxaliplatin or irinotecan show no synergy in human colorectal cancer trials, and sub-additive killing is observed in colorectal cancer cell lines.\"}]","An RNA damage response network mediates the lethality of 5-FU in colorectal cancer | PDF",1790044937,68,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7898973f966f88656650fb9ccfdfec4.webp",983,1276,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30e18ea995a56bbfcb69b156436e3222.webp",982,1275,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97ba800a97c72fa71ff97d4978133a26.webp",981,1273,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d2bc731e5cee39b8a99ea66eee7c105.webp",980,1272]